Albert Farrugia, University of Western Australia
Blood safety and availability – current and emerging issues. Presentation
William Murphy, Irish Blood Transfusion Service, Ireland
Impact of MSM donor deferrals on safety and supply. Presentation
Marijke van den Berg, University Hospital of Utrecht, Netherlands
EMA guidelines on transparency for clinical trials. Presentation
Albert Farrugia, University of Western Australia
Barriers to access in the developing world. Presentation
Kathleen Rowe, Blood Centers of America (BCA), USA
The changing economics of blood collection. Presentation
Brian O’Mahony, Irish Haemophilia Society, Ireland
Tender & procurement – challenges and opportunities. Presentation
Assad Haffar, World Federation of Hemophilia (WFH)
Expansion of the WFH Humanitarian Aid program. Presentation
Alfonso Iorio, McMaster University, Canada
How to measure progress in the provision of care for hemophilia. Presentation
Mark Brooker, World Federation of Hemophilia (WFH)
Inclusion of DDAVP on WHO Essential Medicines List and implications for access. Presentation
Magdy El Ekiaby, Shabrawishi Hospital, Egypt
Outcomes of low-dose prophylaxis in children. Presentation